Literature DB >> 20832021

The tumor microenvironment and DNA repair.

Thomas J Klein1, Peter M Glazer.   

Abstract

Genetic instability is one of the hallmarks of cancer cells. As tumors grow, they progressively acquire mutations that ultimately allow them to invade normal tissues and metastasize to distant sites. This increased propensity for mutation also leads to cancers that are resistant to therapeutic intervention. Recent evidence has shown that the tumor microenvironment plays a major role in the etiology of this phenomenon; as tumors are exposed to repeated cycles of hypoxia and reoxygenation, they downregulate a number of DNA repair pathways, thus leading to genetic instability. Understanding the mechanisms involved in this process may provide insights into the development of novel treatment strategies.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20832021      PMCID: PMC2948843          DOI: 10.1016/j.semradonc.2010.05.006

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  35 in total

1.  E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints.

Authors:  Bing Ren; Hieu Cam; Yasuhiko Takahashi; Thomas Volkert; Jolyon Terragni; Richard A Young; Brian David Dynlacht
Journal:  Genes Dev       Date:  2002-01-15       Impact factor: 11.361

Review 2.  Clinical implications of the p53 gene.

Authors:  D Sidransky; M Hollstein
Journal:  Annu Rev Med       Date:  1996       Impact factor: 13.739

3.  The clonal evolution of tumor cell populations.

Authors:  P C Nowell
Journal:  Science       Date:  1976-10-01       Impact factor: 47.728

Review 4.  DNA repair in eukaryotes.

Authors:  R D Wood
Journal:  Annu Rev Biochem       Date:  1996       Impact factor: 23.643

5.  ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation.

Authors:  Ester M Hammond; Mary Jo Dorie; Amato J Giaccia
Journal:  J Biol Chem       Date:  2003-01-07       Impact factor: 5.157

6.  Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells.

Authors:  G C Rice; C Hoy; R T Schimke
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

7.  Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells.

Authors:  Ranjit S Bindra; Paul J Schaffer; Alice Meng; Jennifer Woo; Kårstein Måseide; Matt E Roth; Paul Lizardi; David W Hedley; Robert G Bristow; Peter M Glazer
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

8.  Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells.

Authors:  S D Young; R S Marshall; R P Hill
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

Review 9.  Mitomycin C: a prototype bioreductive agent.

Authors:  A C Sartorelli; W F Hodnick; M F Belcourt; M Tomasz; B Haffty; J J Fischer; S Rockwell
Journal:  Oncol Res       Date:  1994       Impact factor: 5.574

10.  E2F6 negatively regulates BRCA1 in human cancer cells without methylation of histone H3 on lysine 9.

Authors:  Matthew J Oberley; David R Inman; Peggy J Farnham
Journal:  J Biol Chem       Date:  2003-08-08       Impact factor: 5.157

View more
  19 in total

1.  Homology-directed repair of DNA nicks via pathways distinct from canonical double-strand break repair.

Authors:  Luther Davis; Nancy Maizels
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-20       Impact factor: 11.205

Review 2.  Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not?

Authors:  Katrien De Bock; Massimiliano Mazzone; Peter Carmeliet
Journal:  Nat Rev Clin Oncol       Date:  2011-05-31       Impact factor: 66.675

3.  Targeting of β1 integrins impairs DNA repair for radiosensitization of head and neck cancer cells.

Authors:  E Dickreuter; I Eke; M Krause; K Borgmann; M A van Vugt; N Cordes
Journal:  Oncogene       Date:  2015-06-15       Impact factor: 9.867

4.  Intratumoral CD8+ T-cell Apoptosis Is a Major Component of T-cell Dysfunction and Impedes Antitumor Immunity.

Authors:  Brendan L Horton; Jason B Williams; Alexandra Cabanov; Stefani Spranger; Thomas F Gajewski
Journal:  Cancer Immunol Res       Date:  2017-11-02       Impact factor: 11.151

5.  YU238259 Is a Novel Inhibitor of Homology-Dependent DNA Repair That Exhibits Synthetic Lethality and Radiosensitization in Repair-Deficient Tumors.

Authors:  Gregory C Stachelek; Elizabeth Peterson-Roth; Yanfeng Liu; Rafael J Fernandez; Luke R G Pike; Jack M Qian; Laura Abriola; Denton Hoyer; William Hungerford; Janie Merkel; Peter M Glazer
Journal:  Mol Cancer Res       Date:  2015-06-26       Impact factor: 5.852

Review 6.  Evolutionary dynamics of carcinogenesis and why targeted therapy does not work.

Authors:  Robert J Gillies; Daniel Verduzco; Robert A Gatenby
Journal:  Nat Rev Cancer       Date:  2012-06-14       Impact factor: 60.716

7.  Equating salivary lactate dehydrogenase (LDH) with LDH-5 expression in patients with oral squamous cell carcinoma: An insight into metabolic reprogramming of cancer cell as a predictor of aggressive phenotype.

Authors:  Tajindra Singh Saluja; Anita Spadigam; Anita Dhupar; Shaheen Syed
Journal:  Tumour Biol       Date:  2015-11-15

8.  The cytotoxic effect of β-elemene against malignant glioma is enhanced by base-excision repair inhibitor methoxyamine.

Authors:  Yongjian Zhu; Jue Hu; Fang Shen; Hong Shen; Weiguo Liu; Jianmin Zhang
Journal:  J Neurooncol       Date:  2013-05-23       Impact factor: 4.130

9.  The role of cell density and intratumoral heterogeneity in multidrug resistance.

Authors:  Orit Lavi; James M Greene; Doron Levy; Michael M Gottesman
Journal:  Cancer Res       Date:  2013-10-25       Impact factor: 12.701

10.  Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI.

Authors:  Rafal Panek; Liam Welsh; Lauren C J Baker; Maria A Schmidt; Kee H Wong; Angela M Riddell; Dow-Mu Koh; Alex Dunlop; Dualta Mcquaid; James A d'Arcy; Shreerang A Bhide; Kevin J Harrington; Christopher M Nutting; Georgina Hopkinson; Cheryl Richardson; Carol Box; Suzanne A Eccles; Martin O Leach; Simon P Robinson; Kate L Newbold
Journal:  Clin Cancer Res       Date:  2017-03-17       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.